Effectiveness of nafamostat mesilate on glomerulonephritis in immune-complex diseases.
Miyata
T
T
Fujita
Y
Y
Inagi
R
R
Inoue
I
I
Sugiyama
S
S
Maeda
K
K
D001550:Benzamidines; D003169:Complement Inactivator Proteins / Q000627:therapeutic use*; D003449:Cryoglobulinemia / Q000150:complications; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000209:etiology; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D007105:Immune Complex Diseases / Q000150:complications*; D008181:Lupus Nephritis / Q000188:drug therapy
D001550:Benzamidines; D003169:Complement Inactivator Proteins; D006146:Guanidines; C032855:nafamostat